Peter H Sonksen
Overview
Explore the profile of Peter H Sonksen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
371
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Guha N, Nevitt S, Francis M, Bohning W, Bohning D, Sonksen P, et al.
Clin Endocrinol (Oxf)
. 2020 Nov;
94(4):551-562.
PMID: 33249593
Objective: Previous studies suggested that recombinant human IGF-1 (rhIGF-1) administration affects carbohydrate and lipid metabolism in healthy people and in people with diabetes. This study aimed to determine the effects...
2.
Bohning D, Bohning W, Guha N, Cowan D, Bartlett C, Sonksen P, et al.
BMC Res Notes
. 2018 Sep;
11(1):650.
PMID: 30185229
Objective: The GH-2000 biomarker test has been introduced by the World Anti-Doping Agency as a method of detecting growth hormone misuse in professional sport. The test involves the measurement insulin-like...
3.
Sonksen P, Holt R, Bohning W, Guha N, Cowan D, Bartlett C, et al.
Clin Diabetes Endocrinol
. 2018 Feb;
4:3.
PMID: 29445518
Background: Endocrine profiles have been measured on blood samples obtained immediately post-competition from 693 elite athletes from 15 Olympic Sports competing at National or International level; four were subsequently excluded...
4.
Sonksen P, Bavington L, Boehning T, Cowan D, Guha N, Holt R, et al.
Br J Sports Med
. 2018 Jan;
52(23):1481-1482.
PMID: 29351951
No abstract available.
5.
Bohning D, Bohning W, Guha N, Cowan D, Sonksen P, Holt R
BMC Med Res Methodol
. 2016 Nov;
16(1):164.
PMID: 27894262
No abstract available.
6.
Bohning D, Bohning W, Guha N, Cowan D, Sonksen P, Holt R
BMC Med Res Methodol
. 2016 Oct;
16(1):147.
PMID: 27793179
Background: The GH-2000 score has been developed as a powerful and unique technique for the detection of growth hormone misuse by sportsmen and women. The score depends upon the measurement...
7.
Sonksen P, Cowan D, Holt R
Lancet Diabetes Endocrinol
. 2016 Aug;
4(11):882-883.
PMID: 27542991
No abstract available.
8.
Holt R, Guha N, Bohning W, Bartlett C, Cowan D, Sonksen P, et al.
Drug Test Anal
. 2016 Feb;
9(1):30-37.
PMID: 26888146
Insulin-like growth factor-I (IGF-I) is abused by elite athletes for its metabolic and anabolic effects. We have previously shown that it is possible to detect IGF-I misuse by measuring serum...
9.
Guha N, Nevitt S, Francis M, Woodland J, Bohning D, Sonksen P, et al.
J Clin Endocrinol Metab
. 2015 Jun;
100(8):3126-31.
PMID: 26046967
Context: IGF-I is thought to mediate many of the anabolic actions of GH, and there are anecdotal reports that IGF-I is misused by elite athletes. There is no published evidence...
10.
Holt R, Bohning W, Guha N, Bartlett C, Cowan D, Giraud S, et al.
Drug Test Anal
. 2015 Feb;
7(9):745-55.
PMID: 25645199
The GH-2000 and GH-2004 projects have developed a method for detecting GH misuse based on measuring insulin-like growth factor-I (IGF-I) and the amino-terminal pro-peptide of type III collagen (P-III-NP). The...